90-d survivors | 90-d non-survivors | p-value | |
---|---|---|---|
Vegetation size (mm) | 23.5 ± 8.7 | 35 ± 7.1 | 0.099 |
Bypass time (min) | 130.4 ± 70.9 | 219.5 ± 120.9 | 0.126 |
Cross clamp time (min) | 86.7 ± 44.4 | 136 ± 84.9 | 0.189 |
Operation duration (min) | 219 ± 78 | 385 ± 148 | 0.016 |
Type of valve surgery | 0.189 | ||
Mechanical prosthesis | 11 (61.1%) | 0 | |
Biological prosthesis | 6 (33.3%) | 2 (100%) | |
Reconstruction | 1 (5.6%) | 0 | |
Site of valve surgery | 0.113 | ||
Aortic | 4 (22.2%) | 0 | |
Mitral | 2 (11.1%) | 0 | |
Tricuspid | 7 (38.9%) | 1 (50%) | |
Aortic and mitral | 2 (11.1%) | 0 | |
Aortic and tricuspid | 1 (5.6%) | 0 | |
Mitral and tricuspid | 2 (11.1%) | 0 | |
Aortic, mitral and pulmonary | 0 | 1 (50%) | |
Multivalve surgery | 5 (27.8%) | 1 (50%) | 0.521 |
RBC (mL) | 1267 ± 883 | 2900 ± 141 | 0.020 |
FFP (mL) | 433 ± 441 | 200 ± 283 | 0.479 |
Platelets (mL) | 267 ± 305 | 440 ± 622 | 0.503 |
Atrial fibrillation | 11 (61.1%) | 2 (100%) | 0.521 |
AV-block | 4 (23.5%) | 1 (50%) | 0.468 |
Permanent pacemaker | 2 (11.8%) | 0 | 1.000 |
Renal failure | 5 (27.8%) | 2 (100%) | 0.111 |
Coagulation disorder | 3 (17.6%) | 1 (50%) | 0.386 |
Reopening for bleeding | 0 | 0 | |
CVA | 0 | 0 |